Provided by Tiger Trade Technology Pte. Ltd.

Greenfire Resources Ltd

6.23
+0.08501.38%
Volume:2.68M
Turnover:16.67M
Market Cap:1.49B
PE:-24.80
High:6.32
Open:6.26
Low:6.15
Close:6.14
52wk High:7.16
52wk Low:4.15
Shares:240.00M
Float Shares:65.27M
Volume Ratio:5.54
T/O Rate:4.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2510
EPS(LYR):0.4786
ROE:-3.63%
ROA:0.48%
PB:1.85
PE(LYR):13.01

Loading ...

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

GlobeNewswire
·
Sep 17

Oil Stocks Retail Investors Are Watching For Direct Crude Price Exposure

Simply Wall St.
·
Aug 31

Canadian Stocks Decline 0.1% in Early Trading

Dow Jones
·
Aug 17

Canadian Stocks Rise 0.7%

Dow Jones
·
Aug 08

Canadian Stocks Flat in Early Trading

Dow Jones
·
Aug 06

Greenfire Resources Q2 EPS $0.31 Down From $0.50 YoY, Sales $129.597M Up From $104.422M YoY

Benzinga Earnings
·
Aug 05

Greenfire Resources Ltd. Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 05

Thomas Ebbern Bought 255% More Shares In Greenfire Resources

Simply Wall St.
·
Jul 16

RBC Capital Reaffirms Their Hold Rating on Greenfire Resources (GFR)

TIPRANKS
·
Jul 16

Greenfire Resources initiated with a Sector Perform at RBC Capital

TIPRANKS
·
Jul 06

Funds: An Old-School Value Fund With No Tech Is Beating the Market -- Barron's

Dow Jones
·
Jun 20

How This Old-School Value Fund With No Tech Stocks Is Beating the Market -- Barrons.com

Dow Jones
·
Jun 17

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22

Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Greenfire Resources Ltd expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
May 02

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

GlobeNewswire
·
Apr 07

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 24